The natural history of duodenal ulcer disease

G. Battaglia, F. Di Mario, P. Dotto, G. Leandro, M. Plebani, F. Vianello, R. Naccarato

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

With a view to describing the natural history of duodenal ulcer, currently linked with powerful and widely used drugs, we retrospectively reviewed all patients followed-up at our unit between 1978 and 1989. All DU subjects with at least 5 years of clinical-endoscopic follow-up were admitted to the study. Concomitant gastric ulcer, previous gastrointestinal surgery and treatment other than with H2-blockers (where necessary) were considered exclusion criteria. Forty-four patients (35 males, 9 females, mean age 44.5) proved eligible for this study. At monthly intervals in the patients' history of ulcer disease (starting from a baseline month 0 when ulcer symptoms first appeared), we compared all cases in which the duration of disease coincided, i.e. for each month of the clinical course of the ulcer there was a certain number of patients at the same point in time; patients' histories coincided variously over a period ranging from 0 to 15 years. We considered endoscopically-diagnosed relapses (both symptomatic and asymptomatic) and hemorrhages as marker events for the activity of DU disease. A year-by-year duodenal ulcer activity rate was obtained for both treated and untreated subjects, as follows: No. of events/mean No. of patients followed-up per month x 100. Fisher's exact test and multivariate analysis (stepwise logistic regression) were used to investigate risk factors of poor outcome. We found that the years between the 1st and 5th and between the 10th and 15th from the onset of duodenal ulcer disease had higher peaks of activity, mostly in untreated subjects. Cigarette smoking, alcohol consumption, duration of duodenal ulcer history, duodenal ulcer clinical picture at onset and presence of concomitant diseases emerged as risk factors of either relapse or hemorrhage.

Original languageEnglish
Pages (from-to)139-143
Number of pages5
JournalHepato-Gastroenterology
Volume39
Issue number2
Publication statusPublished - 1992

Fingerprint

Duodenal Diseases
Duodenal Ulcer
Ulcer
Hemorrhage
Recurrence
Stomach Ulcer
Alcohol Drinking
Multivariate Analysis
Logistic Models
Smoking
Pharmaceutical Preparations

Keywords

  • Alcohol consumption
  • Bleeding duodenal ulcer
  • Duodenal ulcer history
  • Duodenal ulcer therapy
  • Smoking habit

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Battaglia, G., Di Mario, F., Dotto, P., Leandro, G., Plebani, M., Vianello, F., & Naccarato, R. (1992). The natural history of duodenal ulcer disease. Hepato-Gastroenterology, 39(2), 139-143.

The natural history of duodenal ulcer disease. / Battaglia, G.; Di Mario, F.; Dotto, P.; Leandro, G.; Plebani, M.; Vianello, F.; Naccarato, R.

In: Hepato-Gastroenterology, Vol. 39, No. 2, 1992, p. 139-143.

Research output: Contribution to journalArticle

Battaglia, G, Di Mario, F, Dotto, P, Leandro, G, Plebani, M, Vianello, F & Naccarato, R 1992, 'The natural history of duodenal ulcer disease', Hepato-Gastroenterology, vol. 39, no. 2, pp. 139-143.
Battaglia G, Di Mario F, Dotto P, Leandro G, Plebani M, Vianello F et al. The natural history of duodenal ulcer disease. Hepato-Gastroenterology. 1992;39(2):139-143.
Battaglia, G. ; Di Mario, F. ; Dotto, P. ; Leandro, G. ; Plebani, M. ; Vianello, F. ; Naccarato, R. / The natural history of duodenal ulcer disease. In: Hepato-Gastroenterology. 1992 ; Vol. 39, No. 2. pp. 139-143.
@article{d2ba19cff9a8408691389495a8007580,
title = "The natural history of duodenal ulcer disease",
abstract = "With a view to describing the natural history of duodenal ulcer, currently linked with powerful and widely used drugs, we retrospectively reviewed all patients followed-up at our unit between 1978 and 1989. All DU subjects with at least 5 years of clinical-endoscopic follow-up were admitted to the study. Concomitant gastric ulcer, previous gastrointestinal surgery and treatment other than with H2-blockers (where necessary) were considered exclusion criteria. Forty-four patients (35 males, 9 females, mean age 44.5) proved eligible for this study. At monthly intervals in the patients' history of ulcer disease (starting from a baseline month 0 when ulcer symptoms first appeared), we compared all cases in which the duration of disease coincided, i.e. for each month of the clinical course of the ulcer there was a certain number of patients at the same point in time; patients' histories coincided variously over a period ranging from 0 to 15 years. We considered endoscopically-diagnosed relapses (both symptomatic and asymptomatic) and hemorrhages as marker events for the activity of DU disease. A year-by-year duodenal ulcer activity rate was obtained for both treated and untreated subjects, as follows: No. of events/mean No. of patients followed-up per month x 100. Fisher's exact test and multivariate analysis (stepwise logistic regression) were used to investigate risk factors of poor outcome. We found that the years between the 1st and 5th and between the 10th and 15th from the onset of duodenal ulcer disease had higher peaks of activity, mostly in untreated subjects. Cigarette smoking, alcohol consumption, duration of duodenal ulcer history, duodenal ulcer clinical picture at onset and presence of concomitant diseases emerged as risk factors of either relapse or hemorrhage.",
keywords = "Alcohol consumption, Bleeding duodenal ulcer, Duodenal ulcer history, Duodenal ulcer therapy, Smoking habit",
author = "G. Battaglia and {Di Mario}, F. and P. Dotto and G. Leandro and M. Plebani and F. Vianello and R. Naccarato",
year = "1992",
language = "English",
volume = "39",
pages = "139--143",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "2",

}

TY - JOUR

T1 - The natural history of duodenal ulcer disease

AU - Battaglia, G.

AU - Di Mario, F.

AU - Dotto, P.

AU - Leandro, G.

AU - Plebani, M.

AU - Vianello, F.

AU - Naccarato, R.

PY - 1992

Y1 - 1992

N2 - With a view to describing the natural history of duodenal ulcer, currently linked with powerful and widely used drugs, we retrospectively reviewed all patients followed-up at our unit between 1978 and 1989. All DU subjects with at least 5 years of clinical-endoscopic follow-up were admitted to the study. Concomitant gastric ulcer, previous gastrointestinal surgery and treatment other than with H2-blockers (where necessary) were considered exclusion criteria. Forty-four patients (35 males, 9 females, mean age 44.5) proved eligible for this study. At monthly intervals in the patients' history of ulcer disease (starting from a baseline month 0 when ulcer symptoms first appeared), we compared all cases in which the duration of disease coincided, i.e. for each month of the clinical course of the ulcer there was a certain number of patients at the same point in time; patients' histories coincided variously over a period ranging from 0 to 15 years. We considered endoscopically-diagnosed relapses (both symptomatic and asymptomatic) and hemorrhages as marker events for the activity of DU disease. A year-by-year duodenal ulcer activity rate was obtained for both treated and untreated subjects, as follows: No. of events/mean No. of patients followed-up per month x 100. Fisher's exact test and multivariate analysis (stepwise logistic regression) were used to investigate risk factors of poor outcome. We found that the years between the 1st and 5th and between the 10th and 15th from the onset of duodenal ulcer disease had higher peaks of activity, mostly in untreated subjects. Cigarette smoking, alcohol consumption, duration of duodenal ulcer history, duodenal ulcer clinical picture at onset and presence of concomitant diseases emerged as risk factors of either relapse or hemorrhage.

AB - With a view to describing the natural history of duodenal ulcer, currently linked with powerful and widely used drugs, we retrospectively reviewed all patients followed-up at our unit between 1978 and 1989. All DU subjects with at least 5 years of clinical-endoscopic follow-up were admitted to the study. Concomitant gastric ulcer, previous gastrointestinal surgery and treatment other than with H2-blockers (where necessary) were considered exclusion criteria. Forty-four patients (35 males, 9 females, mean age 44.5) proved eligible for this study. At monthly intervals in the patients' history of ulcer disease (starting from a baseline month 0 when ulcer symptoms first appeared), we compared all cases in which the duration of disease coincided, i.e. for each month of the clinical course of the ulcer there was a certain number of patients at the same point in time; patients' histories coincided variously over a period ranging from 0 to 15 years. We considered endoscopically-diagnosed relapses (both symptomatic and asymptomatic) and hemorrhages as marker events for the activity of DU disease. A year-by-year duodenal ulcer activity rate was obtained for both treated and untreated subjects, as follows: No. of events/mean No. of patients followed-up per month x 100. Fisher's exact test and multivariate analysis (stepwise logistic regression) were used to investigate risk factors of poor outcome. We found that the years between the 1st and 5th and between the 10th and 15th from the onset of duodenal ulcer disease had higher peaks of activity, mostly in untreated subjects. Cigarette smoking, alcohol consumption, duration of duodenal ulcer history, duodenal ulcer clinical picture at onset and presence of concomitant diseases emerged as risk factors of either relapse or hemorrhage.

KW - Alcohol consumption

KW - Bleeding duodenal ulcer

KW - Duodenal ulcer history

KW - Duodenal ulcer therapy

KW - Smoking habit

UR - http://www.scopus.com/inward/record.url?scp=0026532830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026532830&partnerID=8YFLogxK

M3 - Article

C2 - 1634181

AN - SCOPUS:0026532830

VL - 39

SP - 139

EP - 143

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 2

ER -